Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|September 3, 2016
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbiditiesMatthew Dryden, Yingyuan Zhang, David Wilson, et al.
International Journal of Antimicrobial Agents|July 2, 2017
Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the newMichael Z David, Matthew Dryden, Thomas Gottlieb, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infectionsJohn Weigelt, Kamal Itani, Dennis Stevens, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2016
Antimicrobial stewardship in wound care: a Position Paper from the British Society for Antimicrobial Chemotherapy and European Wound Management AssociationBenjamin A Lipsky, Matthew Dryden, Finn Gottrup, et al.
Infectious Diseases and Therapy|July 2, 2020
Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized Trial of Ceftaroline Fosamil Versus Vancomycin Plus AztreonamMiguel Sánchez-García, Jennifer Hammond, Jean Li Yan, et al.
Journal of Global Antimicrobial Resistance|February 22, 2017
Hot topics in reactive oxygen therapy: Antimicrobial and immunological mechanisms, safety and clinical applicationsMatthew Dryden, Jonathan Cooke, Rami Salib, et al.
Infectious Diseases and Therapy|November 6, 2021
Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical TrialsMark Wilcox, Jean Li Yan, Pedro L Gonzalez, et al.
Journal of Global Antimicrobial Resistance|December 18, 2021
Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trialsMatthew Dryden, Michal Kantecki, Jean Li Yan, et al.
Ticks and Tick-Borne Diseases|October 20, 2021
Autochthonous tick-borne encephalitis in the United Kingdom: A second probable human case and local eco-epidemiological findingsChristopher T Mansbridge, Jane Osborne, Maya Holding, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2018
Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and EuropeDavid B Huang, Thomas M File, Matthew Dryden, et al.
Pageof 6